Cardiogenic Shock and Other Pump Failure States

Chapter 8


Cardiogenic Shock and Other Pump Failure States



Although acute circulatory shock occurs as a consequence of a wide variety of conditions, all result in inadequate oxygen delivery to the organs, tissues, and cells, relative to the oxygen requirements of their metabolic activities. The final common pathway of all shock states is an imbalance between oxygen supply and demand. The effects of inadequate tissue perfusion are initially reversible, but prolonged end-organ hypoperfusion leads to cellular hypoxia and the derangement of critical biochemical processes, including (1) cell membrane ion pump dysfunction, (2) intracellular edema, (3) leakage of intracellular contents into the extracellular space, and (4) inadequate regulation of intracellular pH. These abnormalities rapidly become irreversible and result sequentially in cell death, end-organ damage (multiple organ system failure), and death. As a result, the prompt recognition of shock and initiation of therapy are imperative. Despite modern aggressive treatment in the intensive care unit (ICU) setting, the mortality rates from shock remain very high—for example, mortality rates of 50% to 80% are reported for patients with acute myocardial infarction and cardiogenic shock.


Cardiogenic shock occurs when impairment of cardiac pump function results in inadequate tissue perfusion. This chapter focuses on the pathophysiology, clinical diagnosis, and approach to the patient with cardiogenic shock; Chapter 9 discusses shock resulting from low preload, and Chapter 10 discusses shock resulting from the maldistribution of blood flow. Pericardial tamponade and major pulmonary embolus, the two primary causes of obstructive shock, are presented in Chapters 54 and 77, respectively. Chapter 52 addresses acute heart failure syndromes that overlap with cardiogenic shock with regard to specific etiologies.



Pathophysiology



Determinants of Tissue Perfusion


The principal determinants of tissue perfusion are cardiac output and arterial blood pressure. Cardiac output is defined by the relationship in Equation 1 (Box 8.1). Factors that affect ventricular stroke volume include preload, intrinsic myocardial contractility, and afterload (Figures 8.1 to 8.4). Arterial blood pressure represents the driving force for tissue perfusion and can be defined by Equations 2 and 3 (see Box 8.1). Systemic vascular resistance is principally determined by the arterioles. Shock can be caused by a variety of pathophysiologic processes that alter any of these factors, thereby reducing oxygen delivery to the tissues, and these can be organized by hemodynamic alteration as shown in Table 8.1.





image


Figure 8.1 Starling curves” of ventricular function representing the relationship between cardiac output (as the dependent variable) and left ventricular filling (end-diastolic) pressure (LVEDP) (as the independent variable) for myocardial states of normal (A), enhanced (B), and decreased (C) myocardial contractility. Other important independent variables that determine cardiac output, such as afterload (see Figure 8.3), are held constant. In the intensive care unit, LVEDP is normally approximated by pulmonary artery wedge pressure (PAWP). The dashed vertical line at ~18 mm Hg (open arrow) indicates the PAWP at which fluid begins to accumulate in the interstitial space of the lung. The dotted vertical line at ~28 mm Hg (closed arrow) indicates the PAWP at which acute alveolar edema develops. Note that all curves lack “descending limbs” at high filling pressures (i.e., decreasing cardiac outputs at high LVEDP). Descending limbs of Starling curves are considered to be experimental artifacts and may have been due to development of mitral regurgitation at high distending pressures. (See Elzinga G: Starling’s “Law of the heart”: Rise and fall of the descending limb. News Physiol Sci 7:134-137, 1992, for more details about the descending limb.)





image


Figure 8.4 Three Starling curves (dotted lines) relating stroke volume and left ventricular filling pressure with normal (A), moderately decreased (B), and severely decreased (C) myocardial function (Figure 8.1) are superimposed on three curves (solid lines) relating stroke volume and afterload for the same three states of myocardial function (normal, A′; moderately decreased, B′; and severely decreased, C′) (Figure 8.3). Because most vasodilator agents (e.g., nitroprusside) reduce both preload and afterload, their effects on stroke volume depend on the state of myocardial function. For example, when myocardial function is normal, such a vasodilator lowers stroke volume because of the predominant effect caused by lowering preload (as shown by the arrow originating at the intersection of curves A and A′). In contrast, when myocardial function is depressed, such an agent results in improved stroke volume despite a decrease in preload (arrows from the intersections of curves B and B′ and curves C and C′) (similar to point C in Figure 8.2). (Modified from Cohn JN, Franciosa JA: Vasodilator therapy of cardiac failure. N Engl J Med 297:27-31, 1977.)



Stages of Shock


The shock syndrome is characterized by a series of physiologic stages beginning with an initial inciting event that causes acute circulatory compromise. Shock may subsequently progress through three stages, culminating in irreversible end-organ damage and death.






Differential Diagnosis


To initiate appropriate therapy, cardiogenic shock must be differentiated from other categories of shock, such as hypovolemic shock, distributive (low afterload) shock, or obstructive shock. The clinical history, physical examination, and laboratory finding should provide important clues to the shock state’s origin. The use of a balloon-tipped, flow-directed pulmonary artery (Swan-Ganz) catheter can facilitate the initial categorization of the shock state as well as help to identify the individual causes of cardiogenic shock (see Table 8.1 and Box 8.2). Echocardiography with Doppler can provide similar, although more limited assessment of these parameters as well.



Hypovolemia, occurring as a result of blood loss or volume depletion, results in inadequate ventricular preload with resultant decreased stroke volume and cardiac output. Typically, filling pressures (such as the central venous pressure [CVP] and pulmonary artery wedge pressure [PAWP]) are reduced, as is cardiac output. Similarly, impaired left ventricular filling from increased intrapericardial pressure resulting from cardiac tamponade or obstruction to right ventricular outflow secondary to acute massive pulmonary embolism results in reduced left ventricular preload, stroke volume, and cardiac output. Initial treatment is with volume infusion until more definitive therapy is initiated. In patients with left ventricular systolic dysfunction, diastolic dysfunction, or right ventricular dysfunction, “normal” filling pressures may not be adequate to maintain normal cardiac output. Thus, relative hypovolemia may be present despite a “normal” CVP or PAWP. The ideal filling pressures in patients with heart failure are those that allow maximal cardiac output without producing pulmonary edema. Often, patients with chronic heart failure require a PAWP of 16 to 20 mm Hg to maintain adequate cardiac output.


Shock caused by vasodilation or low afterload is termed distributive shock (e.g., shock caused by sepsis or anaphylaxis). Septic shock occurs as a result of endogenous and exogenous biologically active factors, which produce vasodilation and impair oxygen delivery to the tissues. Early septic shock may be associated with increased cardiac output secondary to decreased afterload and increased heart rate, but late septic shock may be associated with profound reduction in cardiac output from myocardial depression resulting from a number of factors. Late septic shock needs to be distinguished from primary cardiogenic shock because the therapy for these conditions differs significantly.

< div class='tao-gold-member'>

Jul 7, 2016 | Posted by in CRITICAL CARE | Comments Off on Cardiogenic Shock and Other Pump Failure States

Full access? Get Clinical Tree

Get Clinical Tree app for offline access